focus -WSS

focus

author：leisure time 2025-08-19 15:02:29 - browse：76

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： In utero gene editing: an explainer

hotspot

WSS

New documents shed light on MD Anderson Cancer Institute feud

Medicare inequities exacerbate Puerto Rico’s health disparities

In utero gene editing: an explainer

My chronic pain journey would have been easier knowing 5 things % STAT

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Sophia Smith scores twice for US in in 3

entertainment

focus

focus

As demand for Covid shots wanes, Moderna seeks its next success

How to protect coverage of PrEP

United colonoscopy coverage change 'may cost lives,' doctors say

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Alkermes shareholders re

Where does female orgasm come from? Scientists think they know

As demand for Covid shots wanes, Moderna seeks its next success

Inside the culture of fear in the White House science office of Eric Lander

Malaria cases in Florida and Texas: Here’s what you need to know

A new nitrogen execution bill also undermines medical licensing

explore

R1 RCM gets $5.8 billion buyout offer from private equity firm

Alabama IVF ruling threatens families facing fatal genetic disease

Alabama frozen embryo ruling has major implications for IVF clinics

With competition flaring, obesity drug hits goal in liver disease study

6 phony surgeries that take placebo to the extreme

Men with early prostate cancer can safely opt out of treatment

leisure time

hotspot

explore

focus